However, this is complicated by studies showing that loss of function of ANGPTL4 or treatment with a blocking antibody significantly lowers hypertriglyceridemia, a known risk factor for atherosclerosis [32,33,93,156], and studies have correlated ANGPTL4 levels with the risk of heart failure [108]. This evidence concerns the gene ANGPTL4 and heart failure.